CharityC.FoxMD

PubMed

• Successful use of rifampin in a patient with Stevens-Johnson syndrome to rifabutin.
  Jennifer R. Yonkof, David E. Tapke, Charity C. Fox, Princess U. Ogbogu
  Annals of Allergy, Asthma & Immunology. 2020-03-10
• 56 citations
  AAAAI Mast Cell Disorders Committee Work Group Report: Mast Cell Activation Syndrome (MCAS) Diagnosis and Management
  Catherine R. Weiler, K. Frank Austen, Cem Akin, Marla S. Barkoff, Jonathan A. Bernstein
  The Journal of Allergy and Clinical Immunology. 2019-10-01
• 8 citations
  Treatment of adult hyper-IgD syndrome with canakinumab.
  Casey Curtis, Charity C. Fox
  The Journal of Allergy and Clinical Immunology. in Practice. 2015-09-01

Journal Articles

• Treatment of Adult Hyper-IgD Syndrome with Canakinumab  
  Curtis, CR and Fox, C.C., J Allergy Clin Immunol Pract, 1/1/2015
• A 42-year-old man with fever, shock, and rash  
  Rahmanian SD, Molenda M, Fox C, Zirwas M, Sood N, Chest, 1/1/2010
• The CD4+ Lymphopenic Sarcoidosis Phenotype is Highly Responsive to Anti-TNF-(alpha) Therapy  
  Crouser E, Lozanski G, Fox C, Hauswirth D, Raveendran R, Julian M, Chest, 1/1/2010
• Clinical Problem Solving: Failure to Respond � a 52-year-old man presented to his primary care physician with dyspnea and cough  
  Ezzie ME, Janssen WJ, O�Brien JM, Fox C, Schwarz MI, N Engl J Med, 1/1/2008
• Skin testing following anaphylaxis to a topical Neosporin preparation  
  Schroer BC, Fox CC, Hauswirth DW, Ann Allergy Asthma Immunol, 1/1/2008
• Th1 and Th2 Cytokine Response to Academic Stress  
  Kang D-H, Fox CC, Res Nurs Health, 1/1/2001
• Neuroendocrine and leukocyte responses and pulmonary function to acute stressors  
  Kang D H, Fox CC, Annals Behav Med, 1/1/2000
• Age-related Defects in Th1 and Th2 Cytokine Production by Human T Cells Can be Dissociated from Altered Frequencies of CD45RA+ and CD45RO+ T cell Subsets  
  Whisler RL, Liu B, Fox CC, Lakshmanan RR, and Karanfilov CI, Mech Aging Dev, 1/1/1999
• Downregulation of Class II antigen Expression by FGF-Heparin complexes is Due Primarily to Heparin Effect  
  Hackshaw KV, Lakshmanan RR, Everett RW and Fox CC, Res Comm Mol Path Pharm, 1/1/1998
• Phosphorylation and coupling of zeta-chains to activated T-cell receptor (TCR)/CD3 complexes from peripheral blood T-cells of elderly humans  
  Whisler RL, Karanfilov CI, Newhouse YG, Fox CC, Lakshmanan RR, and Liu B, Mech Aging Dev, 1/1/1998
• Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells  
  Cooke HJ, Fox P, Alferes, L, Fox CC, and Wolfe SA, Jr, Can J Physiol Pharmacol, 1/1/1998
• IFN-y Stimulated Enhancement of MHC Class II Antigen Expression by the Human Mast Cell Line HMC-1  
  Love KS, Lakshmanan RR, Butterfield JW and Fox CC, Cell Immunol, 1/1/1996
• Rat Peritoneal Mast Cells Present Antigen to a PPD-Specific T Cell Line  
  Fox CC, Jewell SJ, and Whitacre CC, Cell Immunol, 1/1/1994
• Immediate Hypersensitivity Responses in Idiopathic Inflammatory Bowel Disease: Histamine Release from Human Intestinal Mast Cells in Response to Gut Epithelial Proteins  
  Fox CC, Lichtenstein LM and Roche JK, Dig Dis Sci, 1/1/1993
• Modulation of Human Intestinal Mast Cell Mediator Release by Sulfasalazine and 5-Aminosalicylic Acid  
  Fox CC, Moore WC and Lichtenstein LM, Dig Dis Sci, 1/1/1991
• Enhancement of Human Intestinal Mast Cell Mediator Release in Active Ulcerative Colitis  
  Fox CC, Lazenby A, Moore WC, Yardley JH, Bayless TM and Lichtenstein LM, Gastroenterology, 1/1/1990
• Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine or skin  
  Cohan VL, Undem BJ, Fox CC, Adkinson NF Jr, Lichtenstein LM and Schleimer RP, Am Rev Respir Dis, 1/1/1989
• Identification of Chondroitin Sulfate E Proteoglycans and Heparin Proteoglycans in the Secretory Granules of Human Lung Mast Cells  
  Stevens RL, Fox CC, Lichtenstein LM and Austen KF, Proc Natl Acad Sci USA, 1/1/1988
• Comparison of Human Lung and Intestinal Mast Cells  
  Fox CC, Wolf EJ, Kagey-Sobotka A and Lichtenstein LM, J Allergy Clin Immunol, 1/1/1988
• Functional heterogeneity of human mast cells from different anatomical sites: In vitro responses to morphine sulfate  
  Tharp MD, Kagey-Sobotka A, Fox CC, Marone G, Lichtenstein LM and Sullivan TJ, J Allergy Clin Immunol, 1/1/1987
• The pathophysiology of human mast cells: In vitro and in vivo function  
  Peters SP, Schleimer RP, Naclerio RM, MacGlashan DW Jr, Togias AG, Proud D, Freeland HS, Fox CC, Adkinson NF Jr and Lichtenstein LM, Am Rev Respir Dis, 1/1/1987
• Isolation and characterization of human intestinal mucosal mast cells  
  Fox CC, Dvorak AM, Peters SP and Lichtenstein LM, J Immunol, 1/1/1985
• Role of human basophils and mast cells in the pathogenesis of allergic diseases  
  Schleimer RP, Fox CC, Naclerio RM, Plaut M, Creticos PS, Togias AG, Warner JA, Kagey-Sobotka A and Lichtenstein LM, J Allergy Clin Immunol, 1/1/1985
• Mediator release from human basophils and mast cells from lung and intestinal mucosa  
  Fox CC, Kagey-Sobotka A, Schleimer RP, Peters SP, MacGlashan DW and Lichtenstein LM, Int Arch Allergy Appl Immunol, 1/1/1985
• Histamine-containing cells in human peritoneal fluid  
  Fox CC, Dvorak AM, MacGlashan DW Jr and Lichtenstein LM, J Immunol, 1/1/1984
• Join now to see all

Books/Book Chapters

• Human Inflammatory Disease: Clinical Immunology Vol. I. 
  Chapter: In vitro and in vivo studies of human basophils and mast cells: Mediators, secretagogues and pharmacology. 
  Page 39 - 47Kagey-Sobotka A., MacDonald SM, Fox C, Warner JA and Lichtenstein LMEditors: Marone, Lichtenstein, Condorelli, Fauci.B.C. Decker, Toronto, Canada; Philadelphia, PA1988
• Inflammatory Bowel Disease: current status and future approach. Proceedings of the International Symposium on Future Research Approaches to Inflammatory Bowel Disease. 
  Chapter: Enhanced Intestinal Mast Cell Histamine Release in Idiopathic Inflammatory Bowel Disease. 
  Page 355 - 359Fox CC, Moore WC, Bayless TM and Lichtenstein LMEditors: R.P. MacDermott.Excerpta Medica, Amsterdam, The Netherlands1988
• Mast Cell Differentiation and Heterogeneity. 
  Chapter: Heterogeneity in human histamine containing cells. 
  Page 331 - 345Lichtenstein LM, Fox CC, Schleimer RP, Proud D, Naclerio RM and Kagey-Sobotka AEditors: J Bienenstock, AD Befus, and JA Denburg.Raven Press, New York, NY1986
• Proceedings of the 27th Annual A.N. Richard Symposium, "Leukotrienes in Cardiovascular and Pulmonary Function." 
  Chapter: Mast cells and mast cell mediators in models of airways disease. 
  Page 153 - 161Peters SP, Naclerio RM, Freeland HS, Togias A, Schleimer RP, MacGlashan DW Jr, Kagey-Sobotka A, Fox CC, Adkinson NF Jr and Lichtenstein LMEditors: A.M. Lefer.Allen R. Liss, Inc., New York, NY1986
• Proceedings of the XII International Congress of Allergology and Clinical Immunology. 
  Chapter: The pathogenesis of allergic inflammation reflects differences between basophils and mast cells. 
  Page 170 - 174MacGlashan DW, Jr, Warner J, Fox CC, Peters SP and Lichtenstein LMC.V. Mosby Company, St. Louis, MO1986
• Join now to see all

Abstracts/Posters

• Treatment of Adult Hyper-IgD Syndrome with Canakinumab.
  Curtis, CR and Fox CC, Ann Allergy Asthma Immunol, 1/1/2013
• Adult Presentation of Hyper IgD Syndrome: Fevers and IgG subclass deficiency.
  Raveendran R and Fox C, Ann Allergy Asthma Immunol, 1/1/2011
• Adalimumab-induced angioedema in a young woman with Crohns Disease.
  Cho CB, Patterson AM, Fox, CC, Ogbogu PU, Ann Allergy Asthma Immunol, 1/1/2010
• Delayed Onset Vibratory Urticaria Limited to the Hands.
  Stutes SA, Fox CC, Ann Allergy Asthma Immunol, 1/1/2009
• Sarcoidosis Patients with Profound Lymphopenia and Opportunistic Infections.
  Raveendran R, Hauswirth DW, Crouser ED, Fox CC, Ann Allergy Asthma Immunol, 1/1/2008
• Cytokine Production by Human Mast Cell Line HMC-1 Following Stimulation by T Cells and Superantigen.
  Fox CC MD and Lakshmanan RR, J Allergy Clin Immunol, 1/1/1999
• Human Mast Cell Mediated Activation of T Cells by Staphylococcal Exotoxins.
  Fox CC, Love KS, and Lakshmanan RR, J Allergy Clin Immunol, 1/1/1997
• Expression of MHC class II Molecules on HMC-1 Cells is Upregulated by IFN-g but not IL-4.
  Love KS, Lakshmanan RR, Butterfield JH and Fox CC, J Allergy Clin Immunol, 1/1/1996
• Accessory Molecule and MHC class II Expression by Rat Peritoneal Mast Cells Is Not Enhanced by SCF and IFN-g.
  Love KS, Lakshmanan RR, Everett RW and Fox CC, J Allergy Clin Immunol, 1/1/1995
• Accessory Molecule Expression by Rat Mast Cells.
  Fox CC, J Allergy Clin Immunol, 1/1/1994
• Rat Mast Cells Express Accessory Molecules for Antigen Presentation.
  Fox CC and Lakshmanan RR, FASEB J, 1/1/1994
• Rat Peritoneal Mast Cells Express Class II Antigens.
  Fox CC and Jewell, SJ, J Allergy Clin Immunol, 1/1/1993
• Antigen Presentation by Highly Enriched Mast Cell Populations.
  Fox CC and Jewell, SJ, J Immunol, 1/1/1993
• Evidence Against Neurally Mediated Histamine Release in Guinea Pig and Human Ileum.
  Fox CC and Undem BJ, J Allergy Clin Immunol, 1/1/1991
• Monoclonal Antibodies Specific for Human Basophil and Mast Cell Surface Components.
  Fox CC, Wojtas C, Warner JA, Dersch C, Bochner BS and Lichtenstein LM, J Allergy Clin Immunol, 1/1/1990
• Production of Monoclonal Antibodies to Basophil and Mast Cell Surface Antigens.
  Fox CC, Wojtas C, Warner JA, Dersch C, Bochner BS and Lichtenstein LM, FASEB J, 1/1/1990
• Mucosal and connective tissue - type mast cells in normal intestine and idiopathic inflammatory bowel disease.
  Lazenby AJ, Alianiello R, Yardley JH, Harris ML, Bayless TM and Fox CC, Gastroenterology, 1/1/1989
• Neuropeptides Modulate Histamine Release by Human Intestinal Mucosal Mast Cells (HIMMC).
  Fox CC, and Lichtenstein LM, FASEB J, 1/1/1989
• Identification of Chondroitin Sulfate E Proteoglycans and Heparin Proteoglycans in the Secretory Granules of Human Lung Mast Cells.
  Stevens RL, Fox C, Lichtenstein LM, and Austen KF, J Allergy Clin Immunol, 1/1/1988
• Pharmacologic Modulation of Human Gastrointestinal Mast Cell Mediator Release.
  Fox CC, Moore WC, Lichtenstein LM, The Pharmacologist, 1/1/1987
• Immediate Hypersensitivity Responses in Idiopathic Inflammatory Bowel Disease (IBD): Histamine Release from Human Intestinal Mast Cells in Response to Gut Epithelial A...
  Fox CC, Roche JK and Lichtenstein LM, Gastroenterology, 1/1/1987
• Potentiation of Intestinal Mast Cell Mediator Release in Inflamed Tissue.
  Fox CC, Wolf E, Kagey-Sobotka A and Lichtenstein LM, Fed Proc, 1/1/1987
• Inhibition of histamine release from human mucosal mast cells by drugs used in the treatment of inflammatory bowel disease.
  Wolf EJ, Fox CC, Kagey-Sobotka A, Bayless TM and Lichtenstein LM, Gastroenterology, 1/1/1985
• Human intestinal mucosal mast cells: Isolation and comparison to human lung mast cells (LMC).
  Fox CC, Dvorak AM, Peters SP, Kagey-Sobotka A, Wolf EJ and Lichtenstein LM, Fed Proc, 1/1/1985
• The histamine-containing cells of the human peritoneum and gastrointestinal mucosa.
  Fox CC, Dvorak AM and Lichtenstein LM, J Allergy Clin Immunol, 1/1/1984
• Join now to see all

Lectures

• Update on Mast Cell Activation Syndrome 
  Ohio State University - 1/25/2019
• Mast Cell Activation Syndrome: Navigating the Information Maze with Your Patient 
  San Francisco, CA - 1/22/2019
• Angioedema 
  Ohio State University - 1/26/2018
• Update on Mast Cell Disorders 
  Ohio State University - 1/26/2018
• Urticaria and Angioedema 
  Ohio State University, 2002, 2014, 2016, 2017 - 1/1/2017
• Mast Cells Beyond Allergy: Other Roles of Mast Cells 
  Ohio State University - 1/5/2016
• Aiding and Abetting Angioedema: Mast Cell Involvement in Angioedema Pathways 
  Ohio State University - 1/8/2015
• Allergic Rhinitis 
  Ohio State University - 1/28/2014
• Pharmacology Review and Update 
  Ohio State University - 1/12/2014
• Urticaria Update: Role of Autoimmune Disease. 
  Ohio State University - 1/5/2013
• Allergy Immunotherapy: Immunomodulation of the Allergic Response 
  Ohio State University - 1/18/2012
• Urticaria and Angioedema Update 
  Ohio State University - 1/27/2011
• Immunological Testing in Workup of Selected Non-Allergic Conditions Part 1: Celiac Disease 
  Ohio State University - 1/9/2011
• Current Modalities for Treatment of Allergic and Non-Allergic Rhinitis. Pharmacology and Patient Management. 
  Cincinnati, OH, 2010; Columbus, OH, 2010 - 1/28/2010
• Allergic and Non-Allergic Rhinitis 
  Ohio State University - 1/24/2010
• Fellowship in Allergy and Immunology. 
  Ohio State University - 1/21/2010
• Urticaria: Mechanisms and Treatment 
  Ohio State University - 1/5/2010
• Food Allergy and Intolerance 
  Ohio State University - 1/3/2010
• Drug Allergy 
  Ohio State University, 2004, 2007, 2008, 2010 - 1/1/2010
• Chronic Urticaria: Diagnosis and Management 
  Mt. Carmel Medical Center - 1/29/2008
• Current and Future Approaches to Allergy 
  University Hospital East, Ohio State University - 1/27/2008
• Mechanisms of Allergic Disease. 
  Ohio State University - 1/12/2008
• Diagnosis and Management of Rhinitis 
  Ohio State University - 1/4/2007
• Basics of Allergen Immunotherapy 
  Ohio State University - 1/24/2006
• Basics of Testing for Allergy and Immunodeficiency. 
  Ohio State University - 1/15/2006
• Join now to see all

Other

• Recent Advances in the Treatment of Allergies. 
  Fox CC, Ohio Medical Education Network, OMEN TV and Radio
  1/21/2000
• Recent Advances in Allergy. Daily radio presentation and live TV presentation. 
  Fox CC, Ohio Medical Education Network, OMEN TV and Radio
  1/22/1999
• Indications and Use of Steroids in Allergy and Immunology. Daily radio presentation and live TV presentation. 
  Fox CC, Ohio Medical Education Network, OMEN TV and Radio
  1/24/1994